Glibenclamide alleviates β adrenergic receptor activation-induced cardiac inflammation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glibenclamide alleviates β adrenergic receptor activation-induced cardiac inflammation
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-04
DOI
10.1038/s41401-021-00734-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The NLRP3 inflammasome: Mechanism of action, role in disease and therapies
- (2020) Li Wang et al. MOLECULAR ASPECTS OF MEDICINE
- Glyburide, a NLRP3 inhibitor, decreases inflammatory response and is a candidate to reduce pathology in Leishmania braziliensis infection
- (2019) Augusto M. Carvalho et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- An artificial immune and incremental learning inspired novel framework for performance pattern identification of complex electromechanical systems
- (2019) RongXi Wang et al. Science China-Technological Sciences
- Exercise Attenuates Acute β-Adrenergic Overactivation–Induced Cardiac Fibrosis by Modulating Cytokines
- (2019) Akehu Alemasi et al. Journal of Cardiovascular Translational Research
- α1-AR overactivation induces cardiac inflammation through NLRP3 inflammasome activation
- (2019) Jun-zhou Xin et al. ACTA PHARMACOLOGICA SINICA
- β2-adrenergic receptor autoantibodies alleviated myocardial damage induced by β1-adrenergic receptor autoantibodies in heart failure
- (2018) Ning Cao et al. CARDIOVASCULAR RESEARCH
- Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia
- (2018) Charles E. Leonard et al. DIABETES CARE
- A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes
- (2018) Jay C. Jha et al. CLINICAL SCIENCE
- IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult
- (2017) Han Xiao et al. EUROPEAN HEART JOURNAL
- Enemies or weapons in hands: investigational anti-diabetic drug glibenclamide and cancer risk
- (2017) Rui Gao et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effects of stress on the development and progression of cardiovascular disease
- (2017) Mika Kivimäki et al. Nature Reviews Cardiology
- Inflammatory processes in cardiovascular disease: a route to targeted therapies
- (2016) Neil Ruparelia et al. Nature Reviews Cardiology
- Mechanism and Regulation of NLRP3 Inflammasome Activation
- (2016) Yuan He et al. TRENDS IN BIOCHEMICAL SCIENCES
- The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia
- (2015) Jie Liao et al. Nature Communications
- Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice
- (2014) Jian Cai et al. Cardiovascular Diabetology
- The Antidiabetic Agent Glibenclamide Protects Airway Hyperresponsiveness and Inflammation in Mice
- (2014) Wei Cui et al. INFLAMMATION
- K ATP Channels and Cardiovascular Disease
- (2013) Colin G. Nichols et al. CIRCULATION RESEARCH
- Glibenclamide improves kidney and heart structure and function in the adenine-diet model of chronic kidney disease
- (2013) Vishal Diwan et al. PHARMACOLOGICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search